ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

JAMES TANSINDA INTERNAL MEDICINE,MD

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,078Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 302

$362K Total Retail Price of All Prescriptions

Rank: 37 out of 302

250 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 250 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 5,105 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $100 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LISINOPRIL 360 282 1 1
AMLODIPINE BESYLATE 355 288 2 2
METOPROLOL TARTRATE 322 233 3 5
SIMVASTATIN 289 219 4 3
FUROSEMIDE 250 199 5 4
HYDRALAZINE HCL 148 105 6 48
METFORMIN HCL 143 110 7 13
TRAMADOL HCL 136 112 8 16
OMEPRAZOLE 135 99 9 7
WARFARIN SODIUM 132 64 10 8
PANTOPRAZOLE SODIUM 120 89 11 25
PRAVASTATIN SODIUM 108 78 12 17
LEVOTHYROXINE SODIUM 106 86 13 9
MIRTAZAPINE 91 74 14 38
CYMBALTA 83 32 15 74
SANTYL 76 61 16 165
HEPARIN SODIUM 73 68 17 137
CLONIDINE HCL 73 44 17 59
COMBIVENT 67 45 19 139
CARVEDILOL 66 54 20 19
ALENDRONATE SODIUM 66 66 20 49
CIPROFLOXACIN HCL 65 60 22 58
HYDROCHLOROTHIAZIDE 65 54 22 12
GABAPENTIN 64 32 24 18
CLOPIDOGREL 62 57 25 23
ISOSORBIDE MONONITRATE ER 62 47 25 37
FAMOTIDINE 61 38 27 203
ATORVASTATIN CALCIUM 60 47 28 10
GLIPIZIDE 60 52 28 114
CITALOPRAM HBR 58 44 30 30
LEVETIRACETAM 57 41 31 44
ADVAIR DISKUS 56 34 32 61
VALPROIC ACID 55 28 33 269
LANTUS 55 37 33 66
ZOLPIDEM TARTRATE 54 41 35 28
RANITIDINE HCL 52 46 36 33
DONEPEZIL HCL 52 39 36 27
NEXIUM 50 49 38 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 31, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.